eptacog alfa (activated) 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
5159 102786-61-8

Description:

MoleculeDescription

Synonyms:

  • eptacog alfa (activated)
  • eptacog alfa
Eptacog alfa (activated) is recombinant coagulation factor VIIa (rFVIIa) with a molecular mass of approximately 50,000 Daltons produced in baby hamster kidney cells (BHK Cells) by recombinant DNA technology
  • Molecular weight:
  • Formula:
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Feb. 23, 1996 EMA Novo Nordisk A/S

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Hereditary factor VIII deficiency disease indication 28293008 DOID:12134
Glanzmann's thrombasthenia indication 32942005 DOID:2219
Factor VII deficiency indication 37193007 DOID:2215
Hereditary factor IX deficiency disease indication 41788008 DOID:12259




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
4021161 VANDF
C0795575 UMLSCUI
CHEMBL2108405 ChEMBL_ID
CHEMBL2108334 ChEMBL_ID
CHEMBL4297869 ChEMBL_ID
DB00036 DRUGBANK_ID
C103587 MESH_SUPPLEMENTAL_RECORD_UI
253149 RXNORM
116066006 SNOMEDCT_US
428186003 SNOMEDCT_US
006099 NDDF

Pharmaceutical products:

None